2nd Annual Maine Opioid Conference: Discussing the Intersection of Opioid Use Disorder and Infectious Disease in Young Adults
Injection drug use is a well-known route of transmission of blood borne infections, particularly HIV and hepatitis B and C.
According to the Hepatitis B Surveillance Report from 2016, released by the Division of Infectious Disease of Maine Center for Disease Control and Prevention, Maine’s rate of acute hepatitis B increased by 489% from 2015-2016. 45% of all acute hepatitis B cases reported in 2016, were co-infected with hepatitis C.
Hepatitis C epidemiological reports from the Maine CDC note that in 2015, Maine was reported to have the 5th highest rate of acute hepatitis C in the country. From 2015-2016, the rate of acute hepatitis C increased 27% after remaining steady from 2014-2015 and having a drastic 228% increase from 2013-2014.
The primary risk factors for hepatitis B and hepatitis C were injection and non-injection drug use. Through this conference, we will examine harm reduction techniques and preventive measures which can be implemented to stop these drastic trends. Additionally, we will examine the care cascade in the face of co-morbid infectious diseases within the population of people who use drugs.